{
    "code": "02021807",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021807",
    "time": "2020-02-25 12:46:49",
    "許可證字號": "衛署藥輸字第021807號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/08\/16",
    "註銷理由": "屆期未申請展延",
    "有效日期": "96\/07\/16",
    "發證日期": "86\/07\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202180704",
    "中文品名": "富露依木施內服液用顆粒",
    "英文品名": "FLUIMUCIL SYRUP",
    "適應症": "減少呼吸道粘膜分泌之粘稠性。",
    "劑型": "150內服顆粒劑",
    "包裝": "玻璃容器裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0904301100  南洋產業股份有限公司",
        "申請商地址": "台北巿長安東路一段４３巷４號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4800000101",
            "成分名稱": "N-ACETYL-L-CYSTEINE",
            "含量描述": "",
            "含量": "3.0000000000",
            "單位": "GM"
        }
    ]
}